Amgen Rivals Teva With Rituximab Approved For RA

US Market Composed Of Three Biosimilars Plus Rituxan

 
• By Dean Rudge
Approved
Two of three biosimilars now have the RA indication • Source: Shutterstock: PSNPJua

More from Products

More from Generics Bulletin